
TRUSTED BY LEADING Researchers
Failure intelligence runs deeper with Claidex. Every program traced to its preclinical roots.
Maria Joseph
Chief Compliance and Privacy Officer

OF TERMINATED TRIALS LEAVE NO PUBLISHED OUTCOME IN THE LITERATURE
0%
AVERAGE COST OF A TERMINATED PHASE 2 ONCOLOGY TRIAL
0M $
ONCOLOGY TRIALS TERMINATE WITHOUT EXPANSION
0%
UPDATED. AUTOMATED. SOURCED.
Everything in one Claim, from hypothesis to failure.
Claidex was built for researchers and scientists who need the full picture, not a press release.

our impact
The record is growing. So is the signal.
Since launch, Claidex has traced failed programs back to their preclinical roots and put the findings on the public record.
TERMINATED TRIALS COVERED ACROSS ONCOLOGY, NEUROLOGY, AND IMMUNOLOGY
0
UNIQUE MECHANISMS ANALYZED ACROSS ALL PUBLISHED CLAIMS
0
AVERAGE DAYS FROM TRIAL TERMINATION TO PUBLISHED CLAIM
0 mins

frequently Asked Questions

